Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease : a meta-analysis of CKD progression trials
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Clinical journal of the American Society of Nephrology : CJASN - (2024) vom: 16. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fletcher, Robert A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 16.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2215/CJN.0000000000000470 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM37111893X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM37111893X | ||
| 003 | DE-627 | ||
| 005 | 20240416233611.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2215/CJN.0000000000000470 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1377.xml |
| 035 | |a (DE-627)NLM37111893X | ||
| 035 | |a (NLM)38622766 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fletcher, Robert A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease |b a meta-analysis of CKD progression trials |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Herrington, William G |e verfasserin |4 aut | |
| 700 | 1 | |a Agarwal, Rajiv |e verfasserin |4 aut | |
| 700 | 1 | |a Mayne, Kaitlin J |e verfasserin |4 aut | |
| 700 | 1 | |a Arnott, Clare |e verfasserin |4 aut | |
| 700 | 1 | |a Jardine, Meg J |e verfasserin |4 aut | |
| 700 | 1 | |a Mahaffey, Kenneth W |e verfasserin |4 aut | |
| 700 | 1 | |a Perkovic, Vlado |e verfasserin |4 aut | |
| 700 | 1 | |a Staplin, Natalie |e verfasserin |4 aut | |
| 700 | 1 | |a Wheeler, David C |e verfasserin |4 aut | |
| 700 | 1 | |a Chertow, Glenn M |e verfasserin |4 aut | |
| 700 | 1 | |a Heerspink, Hiddo J L |e verfasserin |4 aut | |
| 700 | 1 | |a Neuen, Brendon L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical journal of the American Society of Nephrology : CJASN |d 2006 |g (2024) vom: 16. Apr. |w (DE-627)NLM172123720 |x 1555-905X |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:16 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2215/CJN.0000000000000470 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 16 |c 04 | ||